Refine
Year of publication
Has Fulltext
- yes (41)
Is part of the Bibliography
- no (41)
Keywords
- Actin (1)
- Alleles (1)
- Apoptosis (1)
- Bibliometrics (1)
- Bipolar disorder (1)
- Cardiology (1)
- Chemotherapy (1)
- Consortia (1)
- Density-equalizing mapping (1)
- Depression (1)
- Dilated cardiomyopathy (1)
- Etiology (1)
- Genome-wide association studies (1)
- Heart (1)
- Human behaviour (1)
- KCGS (1)
- Long non-coding RNAs (1)
- Lung Cancer (1)
- Mena/VASP (1)
- Molecular genetics (1)
- Non-small cell lung cancer (1)
- Object vision (1)
- Prognosis (1)
- ROS1 (1)
- Schizophrenia (1)
- Sharp injuries (1)
- Socioeconomic analysis (1)
- Spectrin (1)
- Wounds (1)
- alcoholic hepatitis (1)
- allocation (1)
- alternative splicing (1)
- arachidonate 12/15-lipoxygenase (Alox12/15) (1)
- auditory (1)
- chemogenomic set (1)
- child (1)
- direct-acting antivirals (1)
- drug discovery (1)
- druggable genome (1)
- fourth (1)
- functional magnetic resonance imaging (1)
- graft (1)
- hepatic fibrosis (1)
- hepatitis C virus (1)
- insulin resistance (1)
- kidney (1)
- kinase inhibitor (1)
- lipoxin A4 (1)
- location (1)
- long non-coding RNA (1)
- loss (1)
- multivoxel pattern analysis (1)
- permanent-plot (1)
- phenotypic screening (1)
- pitch (1)
- protein kinase (1)
- re-transplantation (1)
- repeated (1)
- resolution of inflammation (1)
- searchlight analysis (1)
- small molecules (1)
- specialized pro-resolving lipid mediators (SPMs) (1)
- succession scientific terms (1)
- survival (1)
- third (1)
- tight junctions (1)
- understudied kinase (1)
- vascular integrity (1)
- vegetation dynamics (1)
- working memory (1)
Institute
The Kinase Chemogenomic Set (KCGS): An open science resource for kinase vulnerability identification
(2019)
We describe the assembly and annotation of a chemogenomic set of protein kinase inhibitors as an open science resource for studying kinase biology. The set only includes inhibitors that show potent kinase inhibition and a narrow spectrum of activity when screened across a large panel of kinase biochemical assays. Currently, the set contains 187 inhibitors that cover 215 human kinases. The kinase chemogenomic set (KCGS) is the most highly annotated set of selective kinase inhibitors available to researchers for use in cell-based screens.